Drug Profile
CDP 845
Alternative Names: CT 1746Latest Information Update: 17 May 2001
Price :
$50
*
At a glance
- Originator Celltech Group
- Class Antineoplastics; Antirheumatics
- Mechanism of Action Gelatinase inhibitors; Metalloprotease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 17 May 2001 Discontinued-Preclinical for Cancer in United Kingdom (Unknown route)
- 17 May 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 20 Jun 1995 Suspended-Preclinical for Cancer in United Kingdom (Unknown route)